Erlanger, Vanderbilt collaborate on cancer care: 3 things to know 

Erlanger Health System and Vanderbilt-Ingram Cancer Center announced June 26 a new agreement designating VICC as Erlanger's only contracted provider of inpatient and outpatient hematology and oncology services. 

Three things to know: 

1. The agreement's anticipated effective data is Oct. 1 and will include Nashville, Tenn.-based Vanderbilt-Ingram Cancer Center providing hematology and oncology services at Chattanooga, Tenn.-based Erlanger's two clinic and infusion locations. 

2. The partnership will not affect Erlanger's relationship with its medical staff or prevent other hematologist-oncologists from providing care in Erlanger's hospitals. 

3. Erlanger and Vanderbilt over the next year will pursue plans to grow the hematology-oncology collaboration and expand services. 

"This collaborative effort offers a unique and important opportunity for Erlanger to not only access the most clinical trials for adults in cancer care, but also to provide the most comprehensive cancer treatment program in this region," Erlanger Operations Vice President Tanner Goodrich said in a June 26 news release. "By teaming with Vanderbilt, we will be able to continue to expand our cutting-edge cancer care services to the many communities we serve."

More articles on oncology: 
FDA to create website for patient-reported data from cancer clinical trials
Blood tests can identify brain tumors, study suggests
Most US oncologists were anxious at start of pandemic, survey finds

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers